(Q46804039)

English

Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326). (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

Frank V Fossella

2

object named as

Frank Fossella

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

104

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

12

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

2766-2774

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

Non-small cell lung cancer at the extremes of age: impact on diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage IIIB/IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

21 January 2018

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

7 January 2021

based on heuristic

inferred from DOI database lookup

Who gets chemotherapy for metastatic lung cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits of Adding a Drug to a Single-Agent or a 2-Agent Chemotherapy Regimen in Advanced Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

7 January 2021

based on heuristic

inferred from DOI database lookup

Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21495

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21495

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16288485

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46804039&oldid=1584458651"